IMTX Stock Analysis: Buy, Sell, or Hold?

IMTX - Immatics N.V. Ordinary Shares

Biological Products, (No Diagnostic Substances)
$9.95
0.10 (1.02%) ▲
5d: +4.46%
30d: -0.9%
90d: -0.6%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 12, 2026

Get Alerted When IMTX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: IMTX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: IMTX is currently trading at $9.95, which is considered fair relative to its 30-day fair value range of $9.20 to $10.70.

Technical Outlook: Technically, IMTX is showing sideways momentum. Immediate support is located at $9.27, while resistance sits at $10.34.

Market Sentiment: IMTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.89 (+89.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $9.20 - $10.70
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 86.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 89.8% below Wall St target ($18.89)

Trading Range Analysis

30-Day Trading Range $9.20 - $10.70
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $9.27
Resistance Level $10.34
Current Trend Sideways
Technical data as of Jul 2, 2026

Fundamental Context

Forward P/E (Next Year Est.) -5.23
Wall Street Target $18.89 (+89.8%)
Revenue Growth (YoY) -59.0%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 02, 2026 10:42 PM ET
Data refreshes hourly during market hours. Next update: 11:42 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for IMTX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
30 analysts
$436 64 BUY
RARE
Ultragenyx
STRONG BUY
20 analysts
$52 56 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
19 analysts
$102 62 BUY
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$31 58 HOLD
BHVN
Biohaven Ltd.
STRONG BUY
16 analysts
$22 57 HOLD

More Analysis for IMTX

IMTX Technical Chart IMTX Price Prediction IMTX Earnings Date IMTX Investment Advisor IMTX Fair Price Analyzer IMTX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals